Pharmaceutical News

RSS

Revolutionary cancer drugs that target any tumor to be fast-tracked into hospitals by NHS

Patients in England could be some of the first in the world to be treated with revolutionary cancer drugs that can target any type of tumor.

19 Jun 2019

Antidepressant treatment leads to impaired empathy regarding perception of pain

Antidepressant treatment, not only depression per se, can lead to reductions in behavioral and neural responses to pain empathy

18 Jun 2019

FDA approves first non-insulin drug for treatment of pediatric patients with type 2 diabetes

The U.S. Food and Drug Administration today approved Victoza (liraglutide) injection for treatment of pediatric patients 10 years or older with type 2 diabetes.

18 Jun 2019

Blood pressure drug appears to be helpful for people with Alzheimer's disease

Seeking new treatments to slow the progression of Alzheimer's disease, researchers found the blood pressure drug nilvadipine increased blood flow to the brain's memory and learning center among people with Alzheimer's disease without affecting other parts of the brain, according to new research in the American Heart Association's journal Hypertension.

17 Jun 2019

Scientists improve working memory by extending brain signals

Researchers have discovered that short term memory can be improved by artificially extending neuronal signals called sharp wave ripples.

14 Jun 2019

Heart failure drug could be effective in treating leukemia

Canadian researchers followed their intuition that a drug initially intended for heart failure could be effective in treating cancer. Those efforts have borne fruit, as demonstrated by their work published in the Journal of Experimental and Clinical Cancer Research.

13 Jun 2019

Tetrodotoxin found in pufferfish can provide potent pain relief when given properly

Opioids remain a mainstay of treatment for chronic and surgical pain, despite their side effects and risk for addiction and overdose.

13 Jun 2019

Weighing risks and benefits of antidepressant medication for older adults

Depression is a common and serious problem for older adults. Some 15 to 20 percent of people aged 65 and older who live independently deal with symptoms of major depressive disorder.

12 Jun 2019

New method produces opiate antidotes using microorganism found in opium poppy waste

Overdose from opiates has skyrocketed. According to the National Center for Health Statistics, on average, 130 Americans die every day from an opioid overdose.

12 Jun 2019

Chemists build rich collection of natural product-like macrocycles for drug discovery

Natural products, or their close derivatives, make some of our most potent medicines, among which macrocycles with their large carbon-rich ring systems are one class.

12 Jun 2019

Warfarin-treated patients benefit from increasing their vitamin K intake, finds study

When prescribed the anticoagulant drug warfarin, many patients are told to limit foods rich in vitamin K, such as green vegetables.

12 Jun 2019

Researchers find lower opioid prescriptions rates in states that implemented medical cannabis laws

Using data from privately-insured adults, new findings from The University of Texas Medical Branch at Galveston revealed that there is a lower level of opioids prescribed in states that have allowed the use of medical marijuana.

11 Jun 2019

FDA overlooked red flags in drugmaker’s testing of new depression medicine

Ketamine is a darling of combat medics and clubgoers, an anesthetic that can quiet your pain without suppressing breathing and a hallucinogenic that can get you high with little risk of a fatal overdose.

11 Jun 2019

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

Today, the U.S. Food and Drug Administration granted accelerated approval to Polivy (polatuzumab vedotin-piiq), in combination with the chemotherapy bendamustine and a rituximab product (a combination known as "BR"), to treat adult patients with diffuse large B-cell lymphoma (DLBCL) that has progressed or returned after at least two prior therapies.

10 Jun 2019

Diabetes drug reduces cardiovascular events and kidney problems, study finds

A clinical trial that followed more than 9,900 people in 24 countries has found that the drug dulaglutide reduced cardiovascular events and kidney problems in middle-aged and older people with Type 2 diabetes.

10 Jun 2019

New research provides welcomed news for countless patients taking PPIs

For patients taking proton pump inhibitors to treat gastroesophageal disease (GERD) or other acid-related conditions, new research puts safety concerns to rest.

7 Jun 2019

Still-to-be-approved drug proves to be new option for treating active rheumatoid arthritis

In a large-scale, international study led by renowned rheumatologist Josef Smolen from the Department of Medicine III, a still-to-be-approved drug containing the selective janus kinase inhibitor upadacitinib has proved itself to be a new option for treating active rheumatoid arthritis.

7 Jun 2019

New study examines non‐medical use of anti-anxiety medication

There is concern about the misuse of the sedative anti-anxiety medication alprazolam (Xanax®) because of the "high" it can create.

6 Jun 2019

FDA approves first vaccine for prevention of dengue disease in endemic regions

The U.S. Food and Drug Administration announced today the approval of Dengvaxia, the first vaccine approved for the prevention of dengue disease caused by all dengue virus serotypes (1, 2, 3 and 4) in people ages 9 through 16 who have laboratory-confirmed previous dengue infection and who live in endemic areas.

6 Jun 2019

Antihypertensive drug use linked with reduction in dementia risk

Various clinical trials indicate what effects can be expected from standardized intervention programs on the basis of existing evidence.

3 Jun 2019

Pharmaceutical News

Revolutionary cancer drugs that target any tumor to be fast-tracked into hospitals by NHS

Antidepressant treatment leads to impaired empathy regarding perception of pain

FDA approves first non-insulin drug for treatment of pediatric patients with type 2 diabetes

Blood pressure drug appears to be helpful for people with Alzheimer's disease

Scientists improve working memory by extending brain signals

Heart failure drug could be effective in treating leukemia

Tetrodotoxin found in pufferfish can provide potent pain relief when given properly

Weighing risks and benefits of antidepressant medication for older adults

New method produces opiate antidotes using microorganism found in opium poppy waste

Chemists build rich collection of natural product-like macrocycles for drug discovery

Warfarin-treated patients benefit from increasing their vitamin K intake, finds study

Researchers find lower opioid prescriptions rates in states that implemented medical cannabis laws

FDA overlooked red flags in drugmaker’s testing of new depression medicine

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

Diabetes drug reduces cardiovascular events and kidney problems, study finds

New research provides welcomed news for countless patients taking PPIs

Still-to-be-approved drug proves to be new option for treating active rheumatoid arthritis

New study examines non‐medical use of anti-anxiety medication

FDA approves first vaccine for prevention of dengue disease in endemic regions

Antihypertensive drug use linked with reduction in dementia risk

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News